Providing Research Participants With New Information – Is Re-Consent Always Necessary
By Currien MacDonald, MD, CIP, IRB Chair, WCG IRB, and R. Bert Wilkins, JD, MHA, CIP, IRB Chair, WCG IRB
In an ever-changing clinical research landscape, it is critical that we are agile, flexible, and quick to adapt to change. But what if that change impacts currently enrolled study participants? How do we communicate changes to the study effectively and in line with regulatory guidance? This whitepaper provides tips and strategies for how to handle consent documentation with participants when new information becomes available.
VIEW THE WHITE PAPER! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader